503559-76-0 Usage
Uses
Used in Pharmaceutical Research:
(E)-Methyl 4-(2-(benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-enyl)nicotinate is used as a research compound for exploring its potential biological activities and applications in the development of new pharmaceuticals. Its complex structure and functional groups may offer novel interactions with biological targets, contributing to the discovery of new therapeutic agents.
Used in Drug Development:
In the field of drug development, (E)-Methyl 4-(2-(benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-enyl)nicotinate may serve as a lead compound or a structural template for designing new drugs. Its unique features could be exploited to target specific receptors or enzymes, potentially leading to the creation of more effective and selective medications.
Further studies are necessary to fully understand the properties and potential uses of (E)-Methyl 4-(2-(benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-enyl)nicotinate in various fields, including its possible role in the development of novel therapeutics and its interactions with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 503559-76-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,5,5 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 503559-76:
(8*5)+(7*0)+(6*3)+(5*5)+(4*5)+(3*9)+(2*7)+(1*6)=150
150 % 10 = 0
So 503559-76-0 is a valid CAS Registry Number.
503559-76-0Relevant articles and documents
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists
Ladouceur, Gaetan H.,Cook, James H.,Hertzog, Donald L.,Jones,Hundertmark, Thomas,Korpusik, Mary,Lease, Timothy G.,Livingston, James N.,MacDougall, Margit L.,Osterhout, Martin H.,Phelan, Kathleen,Romero, Romulo H.,Schoen, William R.,Shao, Chunning,Smith, Roger A.
, p. 3421 - 3424 (2002)
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl-pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC50=10-25 nM.